An independent expert panel to the U.S. FDA recommended approval of GlaxoSmithKline Plc’s over-the-counter nicotine oral spray that aims to help smokers quit their addiction.
India banned the sale of electronic cigarettes and warned of an “epidemic” among young people, in the latest and potentially biggest move globally against vaping over growing health concerns.
The Trump administration announced plans to remove all flavored e-cigarettes from store shelves in a widening crackdown on vaping, as officials warned that sweet flavors had drawn millions of children into nicotine addiction.
Mallinckrodt Plc hired restructuring firms and may choose to seek bankruptcy protection, Bloomberg reported, sending the drugmaker’s shares down 40 percent.
An Oklahoma judge ordered Johnson & Johnson to pay $572.1 million to the state for the company’s part in fueling an opioid epidemic by deceptively marketing addictive painkillers, a sum substantially less than investors expected, driving up J&J shares.
Researchers at The Scripps Research Institute in Florida published a study in the journal Science describing a newly discovered biological system that manages how cells respond to exposure to opioids.
The FDA proposed new health warnings for cigarette packages and ads due to small size and lack of an image in current warnings.
A divided federal appeals court ruled against Indivior’s bid to stop Dr. Reddy’s Laboratories and Alvogen from selling generic versions of the London-based company’s Suboxone film that infringed the opioid addiction treatment’s patents.
Reckitt Benckiser Group agreed to pay $1.4 billion to settle a U.S. investigation into the sales and marketing of Suboxone Film, a product managed by the spinout company Indivior.
The FDA issued warning letters to two companies for illegally selling unapproved drug products that contain the herbal extract kratom.